Evidence map›Paper›PMID 30147392›Full record

ReviewSubstance abuse and rehabilitation2018

A review of contingency management for the treatment of substance-use disorders: adaptation for underserved populations, use of experimental technologies, and personalized optimization strategies.

Sterling M McPherson, Ekaterina Burduli, Crystal Lederhos Smith, Jalene Herron, Oladunni Oluwoye, Katherine Hirchak, Michael F Orr, Michael G McDonell, John M Roll

2 registry-linked trialsOpen access · goldAbstract readReview
In one paragraph

Review in Substance abuse and rehabilitation, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 51 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed, 1 pooled it
10.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05097547 naunknown statusnot on this mapstarted 2021, after this paper: background citation

Contingency Management for Stimulant Use Disorders

TypeinterventionalSponsorUniversity of VirginiaRan2021 to 2022Enrolled30ConditionsStimulant Use, Contingency ManagementArmsContingency Management
NCT06218056 phase2recruitingnot on this mapstarted 2024, after this paper: background citation

Evaluating the Efficacy of Cannabidiol for Reducing Cigarette Use

TypeinterventionalSponsorUniversity of California, Los AngelesRan2024 to 2026Enrolled120ConditionsTobacco Use Disorder, Tobacco Smoking, Tobacco DependenceArmsCannabidiol (CBD) 800 mg, Placebo
3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 1 synthesis or guideline pooled it, 94 citations in OpenAlex.

  1. The dissemination and implementation of contingency management for substance use disorders: A systematic review.Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors · 2020
    Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Translating strategies for promoting engagement in mobile health: A proof-of-concept microrandomized trial.Health psychology : official journal of the Division of Health Psychology, American Psychological Association · 2021
    Trial
  7. Trial
  8. Trial
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Sterling M McPhersonDepartment of Medical Education and Clinical Sciences, Elson S Floyd College of Medicine, Washington State University, sterling.mcpherson@wsu.edu.
Ekaterina BurduliDepartment of Medical Education and Clinical Sciences, Elson S Floyd College of Medicine, Washington State University, sterling.mcpherson@wsu.edu.
Crystal Lederhos SmithDepartment of Medical Education and Clinical Sciences, Elson S Floyd College of Medicine, Washington State University, sterling.mcpherson@wsu.edu.
Jalene HerronPrograms of Excellence in Addictions Research, Washington State University, sterling.mcpherson@wsu.edu.
Oladunni OluwoyePrograms of Excellence in Addictions Research, Washington State University, sterling.mcpherson@wsu.edu.
Katherine HirchakPrograms of Excellence in Addictions Research, Washington State University, sterling.mcpherson@wsu.edu.
Michael F OrrDepartment of Medical Education and Clinical Sciences, Elson S Floyd College of Medicine, Washington State University, sterling.mcpherson@wsu.edu.
Michael G McDonellDepartment of Medical Education and Clinical Sciences, Elson S Floyd College of Medicine, Washington State University, sterling.mcpherson@wsu.edu.
John M RollDepartment of Medical Education and Clinical Sciences, Elson S Floyd College of Medicine, Washington State University, sterling.mcpherson@wsu.edu.
Washington State University Spokane · USSterling Research Group · US

Funding

Transition to RecoveryP60AA026112 · NIAAA · WASHINGTON STATE UNIVERSITY · PI Denise A Dillard, Michael G McDonell · 2018 to 2026
$10.7M
Research Training/ Education CoreP20MD006871 · NIMHD · WASHINGTON STATE UNIVERSITY · PI BUCHWALD, DEDRA S, PAUL, ROBERTA LYNN · 2012 to 2016
$5.5M
Novel EtG BasedContingency Management for Alcohol in the Severely Mentally IllR01AA020248 · NIAAA · WASHINGTON STATE UNIVERSITY · PI MCDONELL, MICHAEL G · 2012 to 2021
$4.6M
Contingency Management Treatment of Alcohol Abuse American Indian PeopleR01AA022070 · NIAAA · WASHINGTON STATE UNIVERSITY · PI BUCHWALD, DEDRA S, MCDONELL, MICHAEL G · 2013 to 2017
$3.5M
Behavior Change: Reinforcemnt Schedule EffectsR01DA017407 · NIDA · FRIENDS RESEARCH INSTITUTE, INC. · PI ROLL, JOHN M. · 2003 to 2006
$1.1M
NIAAA NIH HHS P60 AA026112NIAAA NIH HHS R01 AA020248NIAAA NIH HHS R01 AA022070NIDA NIH HHS R01 DA017407NIMHD NIH HHS P20 MD006871
6 · The paper itself

Abstract

This review of contingency management (CM; the behavior-modification method of providing reinforcement in exchange for objective evidence of a desired behavior) for the treatment of substance-use disorders (SUDs) begins by describing the origins of CM and how it has come to be most commonly used during the treatment of SUDs. Our core objective is to review, describe, and discuss three ongoing critical advancements in CM. We review key emerging areas wherein CM will likely have an impact. In total, we qualitatively reviewed 31 studies in a systematic fashion after searching PubMed and Google Scholar. We then describe and highlight CM investigations across three broad themes: adapting CM for underserved populations, CM with experimental technologies, and optimizing CM for personalized interventions. Technological innovations that allow for mobile delivery of reinforcers in exchange for objective evidence of a desired behavior will likely expand the possible applications of CM throughout the SUD-treatment domain and into therapeutically related areas (eg, serious mental illness). When this mobile technology is coupled with new, easy-to-utilize biomarkers, the adaptation for individual goal setting and delivery of CM-based SUD treatment in hard-to-reach places (eg, rural locations) can have a sustained impact on communities most affected by these disorders. In conclusion, there is still much to be done, not only technologically but also in convincing policy makers to adopt this well-established, cost-effective, and evidence-based method of behavior modification.

Indexed as

contingency managementdrug- and alcohol-use biomarkersnovel substance-use treatment technologiessubstance-use disorder treatment

Identifiers

PMID30147392
PMCPMC6095117
OpenAlexW2887321850

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.